<p>Data are an average of two macaques. Each pharmacokinetics study was repeated once or twice. (A) Plasma levels (μ g/ml) following injection of mVRC01 at 5mg/kg (blue) or 10mg/kg (red) and VRC01 (10mg/kg, green). The insert shows clearance of the non-mutated VRC01 in each of two macaques on a different scale. (B) Average μ g/kg of two macaques injected with b12 (5 and 7.5 mg/kg), 10E8, 10–1074, PGT121 (each at 5mg/kg). The insert shows a comparison between 10–1074 and mNIH45–46<sup>G54W</sup> both injected at 5mg/kg (C) Comparison of clearance of PGT121 (5mg/kg) as measured by ELISA (μ g/ml) and a pseudovirus-based TZM-bl assay against the RHPA4259.7 isolate (ID50) at different days following i.v. injection into macaques.</p
The pharmacokinetics (PK) of biologic therapeutics, especially monoclonal antibodies (mAbs), in monk...
OBJECTIVE: Daily adult human exposure to bisphenol A (BPA) has been estimated at < 1 mu g/kg, with ...
<p>Concentrations of each of the bnAb that inhibited the target virus at 50–80% was pre-incubated wi...
Two macaques #T769 (blue), T770 (red) received two 5mg/kg injections SC six weeks apart (arrows). An...
<p>(A) Plasma samples from the 11 macaques injected (color coded) were collected 2–3 weeks following...
<p>The numbers of the six macaques injected (2 macaques/gp in three different studies) are indicated...
The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1, and succe...
Four macaques received a SC injection of 5mg/kg and were bled and assayed for circulating PGT121-YTE...
A, B. Live Mtb burden (CFU) in thoracic LNs from cynomolgus (A) and rhesus (B) macaques at various t...
<p>mDC counts are illustrated as a percentage of the baseline mDC counts recorded prior to SIVagmSab...
The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1, and succe...
<p>(A) Changes in plasma viral loads after challenge vaccinated macaques possessing MHC-I haplotype ...
<p>(<b>A</b>) Three groups of macaques (N = 8) were immunized 4 times (V1 to V4) with SIVmac239 deri...
<p>RAG KO mice were injected with 10<sup>10</sup> GC AAV8.CMV.201Ig IA either by IM or IV injection;...
<p>Virus load measured by RT-PCR in tracheal swabs, nose swabs and serum in time and in bronchoalveo...
The pharmacokinetics (PK) of biologic therapeutics, especially monoclonal antibodies (mAbs), in monk...
OBJECTIVE: Daily adult human exposure to bisphenol A (BPA) has been estimated at < 1 mu g/kg, with ...
<p>Concentrations of each of the bnAb that inhibited the target virus at 50–80% was pre-incubated wi...
Two macaques #T769 (blue), T770 (red) received two 5mg/kg injections SC six weeks apart (arrows). An...
<p>(A) Plasma samples from the 11 macaques injected (color coded) were collected 2–3 weeks following...
<p>The numbers of the six macaques injected (2 macaques/gp in three different studies) are indicated...
The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1, and succe...
Four macaques received a SC injection of 5mg/kg and were bled and assayed for circulating PGT121-YTE...
A, B. Live Mtb burden (CFU) in thoracic LNs from cynomolgus (A) and rhesus (B) macaques at various t...
<p>mDC counts are illustrated as a percentage of the baseline mDC counts recorded prior to SIVagmSab...
The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1, and succe...
<p>(A) Changes in plasma viral loads after challenge vaccinated macaques possessing MHC-I haplotype ...
<p>(<b>A</b>) Three groups of macaques (N = 8) were immunized 4 times (V1 to V4) with SIVmac239 deri...
<p>RAG KO mice were injected with 10<sup>10</sup> GC AAV8.CMV.201Ig IA either by IM or IV injection;...
<p>Virus load measured by RT-PCR in tracheal swabs, nose swabs and serum in time and in bronchoalveo...
The pharmacokinetics (PK) of biologic therapeutics, especially monoclonal antibodies (mAbs), in monk...
OBJECTIVE: Daily adult human exposure to bisphenol A (BPA) has been estimated at < 1 mu g/kg, with ...
<p>Concentrations of each of the bnAb that inhibited the target virus at 50–80% was pre-incubated wi...